| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A DNAH3 MYH8 DDX59 MYO7B ATP10B ZRANB3 BPTF DNAH12 MCM9 ATP2C2 DNAH5 HSPA4 HSPA5 ACSL5 HSP90AA4P | 2.64e-06 | 614 | 146 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P | 4.21e-05 | 839 | 146 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P | 4.28e-05 | 840 | 146 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 ASMTL MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P | 4.28e-05 | 840 | 146 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.90e-05 | 28 | 146 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B RGS4 GSPT1 DNAH12 GSPT2 MCM9 ATP2C2 ENTPD6 GNAO1 DNAH5 HSPA5 HSP90AA4P | 5.32e-05 | 775 | 146 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DDX19A DNAH3 MYH8 DDX59 ATP10B DNAH12 MCM9 ATP2C2 DNAH5 HSPA5 HSP90AA4P | 9.91e-05 | 441 | 146 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.31e-04 | 14 | 146 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.63e-04 | 15 | 146 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 2.00e-04 | 16 | 146 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.88e-04 | 18 | 146 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.88e-04 | 18 | 146 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 1.09e-03 | 7 | 146 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 1.09e-03 | 7 | 146 | 2 | GO:0003747 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.64e-05 | 175 | 140 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.64e-05 | 175 | 140 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.98e-05 | 178 | 140 | 8 | GO:0051236 | |
| GeneOntologyBiologicalProcess | pigment catabolic process | 4.85e-05 | 11 | 140 | 3 | GO:0046149 | |
| GeneOntologyBiologicalProcess | heme catabolic process | 4.85e-05 | 11 | 140 | 3 | GO:0042167 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 8.33e-05 | 13 | 140 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 1.05e-04 | 14 | 140 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.20e-04 | 217 | 140 | 8 | GO:0006403 | |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.31e-04 | 15 | 140 | 3 | GO:0043252 | |
| MousePheno | embryonic lethality prior to organogenesis | TRAPPC11 NCAPD3 DDX59 WASHC4 KMT2B TOPBP1 CKAP5 UPF3A TRRAP PRPF40A RGS4 YARS1 GSPT1 NUP205 BPTF IARS2 NF2 PI4KA UGDH FLCN EXOC1 LTV1 DGCR8 TMEM41B HSPA5 TBP | 7.44e-06 | 1204 | 119 | 26 | MP:0013292 |
| MousePheno | anosmia | 2.05e-05 | 7 | 119 | 3 | MP:0004512 | |
| MousePheno | embryonic lethality prior to tooth bud stage | EHBP1 TRAPPC11 NCAPD3 DDX59 WASHC4 KMT2B TOPBP1 CKAP5 UPF3A TRRAP PRPF40A RGS4 YARS1 GSPT1 NUP205 BPTF IARS2 NF2 PI4KA UGDH FLCN EXOC1 LTV1 DGCR8 TMEM41B HSPA5 TBP | 2.99e-05 | 1383 | 119 | 27 | MP:0013293 |
| Domain | Smg4_UPF3 | 6.15e-05 | 2 | 147 | 2 | PF03467 | |
| Domain | Nonsense_mediated_decay_UPF3 | 6.15e-05 | 2 | 147 | 2 | IPR005120 | |
| Domain | PHD | 7.29e-05 | 89 | 147 | 6 | SM00249 | |
| Domain | Znf_PHD | 8.25e-05 | 91 | 147 | 6 | IPR001965 | |
| Domain | OA_transporter | 9.98e-05 | 12 | 147 | 3 | IPR004156 | |
| Domain | OATP | 9.98e-05 | 12 | 147 | 3 | PF03137 | |
| Domain | ZF_PHD_2 | 1.05e-04 | 95 | 147 | 6 | PS50016 | |
| Domain | ZF_PHD_1 | 1.11e-04 | 96 | 147 | 6 | PS01359 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.63e-04 | 14 | 147 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 1.63e-04 | 14 | 147 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.63e-04 | 14 | 147 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.63e-04 | 14 | 147 | 3 | IPR011704 | |
| Domain | AAA_8 | 1.63e-04 | 14 | 147 | 3 | PF12780 | |
| Domain | AAA_5 | 1.63e-04 | 14 | 147 | 3 | PF07728 | |
| Domain | Znf_FYVE_PHD | 1.65e-04 | 147 | 147 | 7 | IPR011011 | |
| Domain | DHC_fam | 2.03e-04 | 15 | 147 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.03e-04 | 15 | 147 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.03e-04 | 15 | 147 | 3 | IPR004273 | |
| Domain | PHD | 3.13e-04 | 75 | 147 | 5 | PF00628 | |
| Domain | HIN_200 | 3.65e-04 | 4 | 147 | 2 | PS50834 | |
| Domain | HIN | 3.65e-04 | 4 | 147 | 2 | PF02760 | |
| Domain | HIN200/IF120x | 3.65e-04 | 4 | 147 | 2 | IPR004021 | |
| Domain | Znf_PHD-finger | 3.98e-04 | 79 | 147 | 5 | IPR019787 | |
| Domain | NA-bd_OB-fold | 5.00e-04 | 83 | 147 | 5 | IPR012340 | |
| Domain | HSR | 6.06e-04 | 5 | 147 | 2 | PS51414 | |
| Domain | HSR | 6.06e-04 | 5 | 147 | 2 | PF03172 | |
| Domain | HSR_dom | 6.06e-04 | 5 | 147 | 2 | IPR004865 | |
| Domain | DAPIN | 6.59e-04 | 22 | 147 | 3 | PS50824 | |
| Domain | PYRIN | 6.59e-04 | 22 | 147 | 3 | SM01289 | |
| Domain | PYRIN | 6.59e-04 | 22 | 147 | 3 | PF02758 | |
| Domain | DAPIN | 6.59e-04 | 22 | 147 | 3 | IPR004020 | |
| Domain | - | DDX19B DDX19A DNAH3 DDX59 MYO7B ZRANB3 GSPT1 NLRP9 DNAH12 GSPT2 N4BP2 MCM9 GNAO1 DNAH5 HYDIN | 8.11e-04 | 746 | 147 | 15 | 3.40.50.300 |
| Domain | P-loop_NTPase | DDX19B DDX19A DNAH3 MYH8 DDX59 MYO7B ZRANB3 GSPT1 NLRP9 DNAH12 GSPT2 N4BP2 MCM9 GNAO1 DNAH5 HYDIN | 1.06e-03 | 848 | 147 | 16 | IPR027417 |
| Domain | ARM-like | 1.36e-03 | 270 | 147 | 8 | IPR011989 | |
| Domain | ARM-type_fold | 1.48e-03 | 339 | 147 | 9 | IPR016024 | |
| Domain | SAND_dom | 1.67e-03 | 8 | 147 | 2 | IPR000770 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.67e-03 | 8 | 147 | 2 | IPR004160 | |
| Domain | SAND | 1.67e-03 | 8 | 147 | 2 | PF01342 | |
| Domain | GTP_EFTU_D3 | 1.67e-03 | 8 | 147 | 2 | PF03143 | |
| Domain | SAND | 1.67e-03 | 8 | 147 | 2 | PS50864 | |
| Domain | SAND | 1.67e-03 | 8 | 147 | 2 | SM00258 | |
| Domain | Zinc_finger_PHD-type_CS | 1.72e-03 | 65 | 147 | 4 | IPR019786 | |
| Domain | - | 1.91e-03 | 222 | 147 | 7 | 1.25.10.10 | |
| Domain | G_TR_CS | 2.14e-03 | 9 | 147 | 2 | IPR031157 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 2.66e-03 | 10 | 147 | 2 | IPR009001 | |
| Domain | Kazal_2 | 2.82e-03 | 36 | 147 | 3 | PF07648 | |
| Domain | Q_MOTIF | 3.05e-03 | 37 | 147 | 3 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 3.05e-03 | 37 | 147 | 3 | IPR014014 | |
| Domain | Secretoglobin | 3.23e-03 | 11 | 147 | 2 | IPR016126 | |
| Domain | Bromodomain | 3.29e-03 | 38 | 147 | 3 | PF00439 | |
| Domain | - | 3.86e-03 | 12 | 147 | 2 | 3.10.390.10 | |
| Domain | - | 3.86e-03 | 12 | 147 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 3.86e-03 | 12 | 147 | 2 | IPR029047 | |
| Domain | SAND_dom-like | 3.86e-03 | 12 | 147 | 2 | IPR010919 | |
| Domain | BROMODOMAIN_2 | 4.09e-03 | 41 | 147 | 3 | PS50014 | |
| Domain | Bromodomain | 4.38e-03 | 42 | 147 | 3 | IPR001487 | |
| Domain | BROMO | 4.38e-03 | 42 | 147 | 3 | SM00297 | |
| Domain | - | 4.38e-03 | 42 | 147 | 3 | 1.20.920.10 | |
| Domain | G_TR_1 | 4.53e-03 | 13 | 147 | 2 | PS00301 | |
| Domain | - | 4.53e-03 | 13 | 147 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 4.53e-03 | 13 | 147 | 2 | IPR018181 | |
| Domain | HSP70_C | 4.53e-03 | 13 | 147 | 2 | IPR029048 | |
| Domain | Dynein_HC_stalk | 5.26e-03 | 14 | 147 | 2 | IPR024743 | |
| Domain | MT | 5.26e-03 | 14 | 147 | 2 | PF12777 | |
| Domain | EF-hand_like | 6.04e-03 | 15 | 147 | 2 | PF09279 | |
| Domain | PI-PLC-Y | 6.04e-03 | 15 | 147 | 2 | PF00387 | |
| Domain | PLCYc | 6.04e-03 | 15 | 147 | 2 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 6.04e-03 | 15 | 147 | 2 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 6.04e-03 | 15 | 147 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 6.04e-03 | 15 | 147 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 6.04e-03 | 15 | 147 | 2 | IPR015359 | |
| Domain | HEAT | 6.38e-03 | 48 | 147 | 3 | PF02985 | |
| Domain | - | 6.87e-03 | 16 | 147 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.87e-03 | 16 | 147 | 2 | SM00146 | |
| Domain | HSP70 | 6.87e-03 | 16 | 147 | 2 | PF00012 | |
| Domain | KAZAL_2 | 7.15e-03 | 50 | 147 | 3 | PS51465 | |
| Domain | Kazal_dom | 7.55e-03 | 51 | 147 | 3 | IPR002350 | |
| Domain | HSP70_2 | 7.74e-03 | 17 | 147 | 2 | PS00329 | |
| Domain | HSP70_1 | 7.74e-03 | 17 | 147 | 2 | PS00297 | |
| Domain | HSP70_3 | 7.74e-03 | 17 | 147 | 2 | PS01036 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.44e-05 | 20 | 108 | 4 | MM14721 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 9.15e-05 | 12 | 108 | 3 | MM15476 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 9.93e-05 | 32 | 108 | 4 | MM14719 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.86e-04 | 15 | 108 | 3 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.86e-04 | 15 | 108 | 3 | MM15697 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR DDX19A RPL27A NCAPD3 HK1 ACAD9 POLR2A KTN1 CKAP5 UPF3B HEATR1 LYAR PRPF40A YARS1 DARS2 ESF1 GSPT1 NUP205 IARS2 PI4KA CSTB LTV1 PRMT3 DNAH5 HSPA4 CLUH HSPA5 | 9.12e-11 | 1425 | 150 | 27 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR DDX19A RPL27A HK1 WASHC4 POLR2A KTN1 CKAP5 HEATR1 LYAR IFI16 TRRAP ESF1 GSPT1 NUP205 LLGL1 PI4KA ASPH UGDH EXOC1 LTV1 PRMT3 PLCG2 HSPA4 HSPA5 | 8.32e-10 | 1353 | 150 | 25 | 29467282 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL27A NCAPD3 KTN1 TOPBP1 CKAP5 UPF3B HEATR1 LYAR TRRAP ESF1 NUP205 BPTF PHF3 MCM9 ASPH LTV1 DGCR8 | 3.51e-08 | 759 | 150 | 17 | 35915203 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR NCAPD3 IFT81 POLR2A KTN1 ZMYND8 CKAP5 HEATR1 TRRAP YARS1 DARS2 NUP205 TRAPPC13 BPTF IARS2 ASMTL PI4KA TBP | 3.58e-08 | 857 | 150 | 18 | 25609649 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR NCAPD3 KMT2B POLR2A ZMYND8 CKAP5 GPATCH8 IFI16 TRRAP PRPF40A ESF1 STRIP1 BPTF PHF3 ASPH AFF1 CLUH | 4.65e-08 | 774 | 150 | 17 | 15302935 |
| Pubmed | RPL27A SP100 MYH8 HK1 IFT81 KTN1 EML6 ATP10B HEATR1 HMOX2 NEB RNF17 PRX ESF1 GSPT1 NUP205 BPTF TNRC18 GSPT2 N4BP2 SCN9A GNAO1 HSPA5 | 6.37e-08 | 1442 | 150 | 23 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DDX19B DDX19A RPL27A SP100 HK1 WASHC4 POLR2A KTN1 UBR7 YARS1 GSPT1 NUP205 GSPT2 ASMTL UGDH CSTB STK39 LTV1 PRMT3 HSPA4 CLUH HSPA5 HSP90AA4P | 7.48e-08 | 1455 | 150 | 23 | 22863883 |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 18296417 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 18492796 | ||
| Pubmed | Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. | 7.86e-08 | 3 | 150 | 3 | 28389619 | |
| Pubmed | Organic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics. | 7.86e-08 | 3 | 150 | 3 | 23986199 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 20949553 | ||
| Pubmed | Synergistic interaction between genetics and disease on pravastatin disposition. | 7.86e-08 | 3 | 150 | 3 | 24613363 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 10833452 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 30955241 | ||
| Pubmed | Influence of drug formulation on OATP1B-mediated transport of paclitaxel. | 7.86e-08 | 3 | 150 | 3 | 24755470 | |
| Pubmed | OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. | 7.86e-08 | 3 | 150 | 3 | 29337310 | |
| Pubmed | Expression of Oatp2 in the Brain and Liver of Alzheimer Disease Mouse Model. | 7.86e-08 | 3 | 150 | 3 | 31967785 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 18413659 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19400585 | ||
| Pubmed | CYLD HK1 PPFIBP1 ACAD9 IFT81 KTN1 HEATR1 HMOX2 PRPF40A DARS2 ESF1 IARS2 LLGL1 TIAM1 NF2 N4BP2 PI4KA ASPH CCDC138 LTV1 HSPA4 CLUH HSPA5 | 1.10e-07 | 1487 | 150 | 23 | 33957083 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RPL27A NCAPD3 SP100 WASHC4 KTN1 CKAP5 HEATR1 HMOX2 GPATCH8 IFI16 PRPF40A STRIP1 NUP205 SP140L PHF3 ASPH TMEM41B CLUH HSPA5 ACSL5 | 2.63e-07 | 1203 | 150 | 20 | 29180619 |
| Pubmed | Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain. | 3.14e-07 | 4 | 150 | 3 | 22294745 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 20644253 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 25280775 | ||
| Pubmed | Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance. | 3.14e-07 | 4 | 150 | 3 | 27777271 | |
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 16452507 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX19B TRAPPC11 DDX19A NCAPD3 HK1 WASHC4 POLR2A ZMYND8 HEATR1 TRRAP DARS2 NUP205 IARS2 PRMT3 DNAH5 | 4.42e-07 | 704 | 150 | 15 | 29955894 |
| Pubmed | TPR RPL27A NCAPD3 KTN1 ZMYND8 CKAP5 LYAR PRPF40A YARS1 AMZ2 IARS2 ASPH UGDH EXOC1 HSPA4 HSPA5 | 4.80e-07 | 809 | 150 | 16 | 32129710 | |
| Pubmed | TPR TCAF2 PPFIBP1 KTN1 YARS1 DARS2 BPTF GSPT2 STK39 EXOC1 HSPA4 | 5.19e-07 | 360 | 150 | 11 | 33111431 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 24194565 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL27A NCAPD3 KMT2B POLR2A KTN1 CEP290 ZMYND8 TOPBP1 CKAP5 HEATR1 GPATCH8 LYAR IFI16 TRRAP PRPF40A BPTF PHF3 ASPH TMEM41B HSPA5 | 8.20e-07 | 1294 | 150 | 20 | 30804502 |
| Pubmed | TPR HK1 POLR2A CKAP5 HEATR1 TRRAP PRPF40A ESF1 NUP205 BPTF IARS2 PHF3 HSPA4 CLUH | 1.01e-06 | 653 | 150 | 14 | 22586326 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.19e-06 | 179 | 150 | 8 | 36261009 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 22232210 | ||
| Pubmed | Analysis of DNA methylation and histone modification profiles of liver-specific transporters. | 1.56e-06 | 6 | 150 | 3 | 19047482 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACAD9 IFT81 POLR2A KTN1 ZMYND8 MEI1 NEB TRRAP DNAH12 SCN9A RBM46 HYDIN | 1.85e-06 | 497 | 150 | 12 | 36774506 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH8 WASHC4 PPFIBP1 UPF3B GPATCH8 TRRAP PRX DARS2 ESF1 CCDC138 FLCN AFF1 MMP1 HSPA4 HSPA5 ATG16L2 | 2.21e-06 | 910 | 150 | 16 | 36736316 |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 9256245 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR RPL27A DNAH3 SP100 HK1 TOPBP1 CKAP5 UPF3B NACAD PRPF40A CSTB LTV1 HSPA4 HSPA5 HSP90AA4P | 4.29e-06 | 847 | 150 | 15 | 35235311 |
| Pubmed | CYLD DDX59 IFT81 POLR2A CEP290 TOPBP1 CKAP5 UPF3B UBR7 PI4KA CCDC138 EXOC1 GNAO1 | 4.90e-06 | 645 | 150 | 13 | 25281560 | |
| Pubmed | TPR KMT2B POLR2A KTN1 HEATR1 TRRAP PRPF40A ESF1 BPTF NF2 PHF3 HSPA5 | 5.10e-06 | 549 | 150 | 12 | 38280479 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EHBP1 DDX19B DDX19A RPL27A HK1 ACAD9 KTN1 LRRC49 UPF3B HEATR1 HMOX2 YARS1 DARS2 ESF1 STRIP1 IARS2 PI4KA CCDC138 MIGA1 CLUH | 7.27e-06 | 1496 | 150 | 20 | 32877691 |
| Pubmed | NCAPD3 KMT2B PPFIBP1 ACAD9 POLR2A KTN1 ZMYND8 TOPBP1 CKAP5 HEATR1 GPATCH8 LYAR TRRAP ESF1 STRIP1 PHF3 PI4KA ASPH DGCR8 TBP | 7.35e-06 | 1497 | 150 | 20 | 31527615 | |
| Pubmed | CYLD RPL27A HK1 PPFIBP1 ARFGEF1 BTBD3 ESF1 STRIP1 IARS2 NF2 PI4KA UGDH DGCR8 RPGR | 7.49e-06 | 777 | 150 | 14 | 35844135 | |
| Pubmed | DDX19B TPR RPL27A POLR2A KTN1 UPF3B UPF3A PRPF40A ESF1 GSPT1 TNRC18 GSPT2 NF2 PHF3 UGDH AFF1 HSPA4 HSPA5 | 7.77e-06 | 1247 | 150 | 18 | 27684187 | |
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 18703564 | ||
| Pubmed | FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. | 9.23e-06 | 10 | 150 | 3 | 9171351 | |
| Pubmed | CYLD DDX19A NCAPD3 ACAD9 HMOX2 DARS2 IARS2 LLGL1 ASPH MIGA1 STK39 PRMT3 CLUH | 9.45e-06 | 686 | 150 | 13 | 28380382 | |
| Pubmed | CYLD RPL27A ZNF234 WASHC4 PPFIBP1 IFT81 CEP290 ZMYND8 CKAP5 NCKAP5 HMOX2 YARS1 TIAM1 NF2 MIGA1 EXOC1 DGCR8 HSPA5 | 1.16e-05 | 1285 | 150 | 18 | 35914814 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR RPL27A DDX59 PPFIBP1 POLR2A KTN1 CKAP5 UPF3B LYAR YARS1 DARS2 GSPT1 GSPT2 ASPH CSTB LTV1 HSPA4 CLUH HSPA5 | 1.18e-05 | 1415 | 150 | 19 | 28515276 |
| Pubmed | DDX19B DDX19A RPL27A NCAPD3 KTN1 CEP290 CKAP5 HEATR1 HMOX2 IFI16 PRPF40A NUP205 NF2 PI4KA EXOC1 HSPA5 ACSL5 | 1.27e-05 | 1168 | 150 | 17 | 19946888 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 TPR RPL27A POLR2A KTN1 ZMYND8 CKAP5 UPF3B HEATR1 PRPF40A ESF1 IARS2 CSTB LTV1 HSPA4 | 1.37e-05 | 934 | 150 | 15 | 33916271 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.51e-05 | 332 | 150 | 9 | 32786267 | |
| Pubmed | 1.51e-05 | 332 | 150 | 9 | 25693804 | ||
| Pubmed | 1.62e-05 | 335 | 150 | 9 | 15741177 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28951524 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17608805 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28754779 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26313692 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15987998 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29944058 | ||
| Pubmed | SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. | 1.85e-05 | 2 | 150 | 2 | 36964102 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 33053215 | ||
| Pubmed | Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. | 1.85e-05 | 2 | 150 | 2 | 23340295 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30684342 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29777022 | ||
| Pubmed | Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis. | 1.85e-05 | 2 | 150 | 2 | 26191226 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24194513 | ||
| Pubmed | Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. | 1.85e-05 | 2 | 150 | 2 | 2917002 | |
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 1.85e-05 | 2 | 150 | 2 | 8186414 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30222506 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24855184 | ||
| Pubmed | Spatial expression of the nonsense-mediated mRNA decay factors UPF3A and UPF3B among mouse tissues. | 1.85e-05 | 2 | 150 | 2 | 37961809 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26474710 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25578040 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20083121 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24989890 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30980272 | ||
| Pubmed | Filament assembly underpins the double-stranded DNA specificity of AIM2-like receptors. | 1.85e-05 | 2 | 150 | 2 | 36864667 | |
| Pubmed | The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps. | 1.85e-05 | 2 | 150 | 2 | 35608258 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17704778 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21719246 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20877131 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 35451102 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16534140 | ||
| Pubmed | Human UPF3A and UPF3B enable fault-tolerant activation of nonsense-mediated mRNA decay. | 1.85e-05 | 2 | 150 | 2 | 35451084 | |
| Pubmed | Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. | 1.85e-05 | 2 | 150 | 2 | 18321482 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18314419 | ||
| Pubmed | OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. | 1.85e-05 | 2 | 150 | 2 | 21691816 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12381297 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22528773 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24418534 | ||
| Pubmed | Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. | 1.85e-05 | 2 | 150 | 2 | 30076839 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28063966 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22240838 | ||
| Pubmed | Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis. | 1.85e-05 | 2 | 150 | 2 | 33036922 | |
| Pubmed | Common Polymorphisms in IFI16 and AIM2 Genes Are Associated With Periodontal Disease. | 1.85e-05 | 2 | 150 | 2 | 28387608 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22613557 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17412826 | ||
| Interaction | DCTN2 interactions | CYLD EHBP1 TPR POLR2A CKAP5 ARFGEF1 UPF3B IFI16 IARS2 N4BP2 CCDC138 RPGR GNAO1 | 2.01e-06 | 356 | 146 | 13 | int:DCTN2 |
| Interaction | PRAP1 interactions | 7.47e-06 | 18 | 146 | 4 | int:PRAP1 | |
| Interaction | HECTD1 interactions | RPL27A NCAPD3 KTN1 TOPBP1 CKAP5 UPF3B HEATR1 LYAR TRRAP PRPF40A ESF1 NUP205 BPTF NF2 PHF3 MCM9 ASPH EXOC1 LTV1 DGCR8 HSPA4 | 8.59e-06 | 984 | 146 | 21 | int:HECTD1 |
| GeneFamily | PHD finger proteins | 6.92e-06 | 90 | 93 | 6 | 88 | |
| GeneFamily | Nucleoporins | 2.11e-05 | 32 | 93 | 4 | 1051 | |
| GeneFamily | Dyneins, axonemal | 8.50e-05 | 17 | 93 | 3 | 536 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 2.59e-04 | 5 | 93 | 2 | 995 | |
| GeneFamily | CD molecules|Toll like receptors | 1.15e-03 | 10 | 93 | 2 | 948 | |
| GeneFamily | DEAD-box helicases | 1.31e-03 | 42 | 93 | 3 | 499 | |
| GeneFamily | Trafficking protein particle complex | 2.29e-03 | 14 | 93 | 2 | 772 | |
| GeneFamily | Heat shock 70kDa proteins | 3.39e-03 | 17 | 93 | 2 | 583 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 4.23e-03 | 19 | 93 | 2 | 131 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.23e-03 | 19 | 93 | 2 | 832 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EHBP1 WASHC4 ZMYND8 TOPBP1 CKAP5 ARFGEF1 TRRAP BPTF TIAM1 PHF3 AFF1 STK39 PRMT3 RPGR | 4.74e-07 | 466 | 149 | 14 | M13522 |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN | 2.27e-06 | 200 | 149 | 9 | M5191 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 1.85e-05 | 198 | 149 | 8 | M5018 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 SP100 WASHC4 ZMYND8 TOPBP1 CKAP5 ARFGEF1 GPATCH8 TRRAP BPTF TIAM1 PHF3 AFF1 STK39 PRMT3 RPGR | 3.11e-05 | 856 | 149 | 16 | M4500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CYLD DDX19B NCAPD3 REXO5 IFT81 HEATR1 GPATCH8 RNF17 ZRANB3 DARS2 ESF1 IARS2 CCDC138 RBM46 LTV1 HERC3 DGCR8 RPGR PLCG2 | 3.28e-06 | 820 | 145 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | DDX19B RPL27A NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 ESF1 NUP205 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2 | 8.33e-06 | 795 | 145 | 18 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DDX19B RPL27A NCAPD3 HEATR1 GPATCH8 LYAR RNF17 ZRANB3 DARS2 ESF1 NUP205 IARS2 GSPT2 CCDC138 RBM46 LTV1 PRMT3 HERC3 | 1.07e-05 | 810 | 145 | 18 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR DDX59 IFT81 KTN1 LRRC49 CEP290 CKAP5 TLR7 TPGS2 UPF3B HEATR1 LYAR PRPF40A ZRANB3 ESF1 GSPT1 BPTF IARS2 PHF3 CCDC138 RPGR GNAO1 HSPA4 | 1.43e-05 | 1257 | 145 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | NCAPD3 HEATR1 RNF17 ZRANB3 ESF1 NUP205 GSPT2 RBM46 LTV1 PRMT3 HERC3 | 1.87e-05 | 333 | 145 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR TRAPPC11 DDX59 CEP290 EML6 CKAP5 NCKAP5 UPF3B HEATR1 LYAR PRPF40A ESF1 IARS2 CFAP54 ATP2C2 CCDC138 HERC3 RPGR GNAO1 HSPA4 | 3.59e-05 | 1060 | 145 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | POU6F2 KTN1 CEP290 EML6 CKAP5 LYAR PRPF40A ESF1 GSPT1 PHF3 N4BP2 HSPA4 HSPA5 | 7.53e-05 | 532 | 145 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | DDX19B NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 NF2 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2 | 1.17e-04 | 799 | 145 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR DDX59 IFT81 KTN1 LRRC49 CEP290 CKAP5 TLR7 TPGS2 UPF3B HEATR1 LYAR PRPF40A ZRANB3 ESF1 GSPT1 BPTF IARS2 PHF3 CCDC138 RPGR GNAO1 HSPA4 | 1.41e-04 | 1459 | 145 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DDX19B NCAPD3 HEATR1 LYAR RNF17 UBR7 ZRANB3 DARS2 NUP205 CCDC138 RBM46 LTV1 PRMT3 HERC3 DGCR8 PLCG2 | 1.61e-04 | 822 | 145 | 16 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.14e-04 | 298 | 145 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.72e-04 | 243 | 145 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-07 | 191 | 150 | 8 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-07 | 191 | 150 | 8 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-07 | 192 | 150 | 8 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.22e-07 | 194 | 150 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-07 | 194 | 150 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-06 | 185 | 150 | 7 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-06 | 185 | 150 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 3.54e-06 | 188 | 150 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-06 | 190 | 150 | 7 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-06 | 192 | 150 | 7 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.20e-06 | 193 | 150 | 7 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.50e-06 | 195 | 150 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.65e-06 | 196 | 150 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.81e-06 | 197 | 150 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 197 | 150 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.97e-06 | 198 | 150 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.97e-06 | 198 | 150 | 7 | 1847ce8c344c8a3e50f3cbbf758a38aba69f85b0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-06 | 199 | 150 | 7 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-06 | 199 | 150 | 7 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.14e-06 | 199 | 150 | 7 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.31e-06 | 200 | 150 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 148 | 150 | 6 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-05 | 148 | 150 | 6 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 154 | 150 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 154 | 150 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.20e-05 | 167 | 150 | 6 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-05 | 169 | 150 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.C1ql2_(Anterodorsal_thalamic_nucleus)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 54 | 150 | 4 | 8a8abf565ea657bf16059c51a63534ede3d7ac12 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-05 | 180 | 150 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-05 | 181 | 150 | 6 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.56e-05 | 182 | 150 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.79e-05 | 184 | 150 | 6 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.79e-05 | 184 | 150 | 6 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 184 | 150 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 184 | 150 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.02e-05 | 186 | 150 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.02e-05 | 186 | 150 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.02e-05 | 186 | 150 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 4.14e-05 | 187 | 150 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.14e-05 | 187 | 150 | 6 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.14e-05 | 187 | 150 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-05 | 188 | 150 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.27e-05 | 188 | 150 | 6 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 407d8a59969d83f014600aae1a55092283a13970 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 4.40e-05 | 189 | 150 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 4.40e-05 | 189 | 150 | 6 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.40e-05 | 189 | 150 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-05 | 189 | 150 | 6 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.53e-05 | 190 | 150 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.53e-05 | 190 | 150 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-05 | 190 | 150 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.66e-05 | 191 | 150 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-05 | 191 | 150 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.66e-05 | 191 | 150 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.66e-05 | 191 | 150 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-05 | 191 | 150 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.66e-05 | 191 | 150 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-05 | 191 | 150 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-05 | 191 | 150 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.66e-05 | 191 | 150 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 191 | 150 | 6 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.66e-05 | 191 | 150 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.80e-05 | 192 | 150 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-05 | 193 | 150 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.94e-05 | 193 | 150 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.94e-05 | 193 | 150 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.94e-05 | 193 | 150 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 194 | 150 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.08e-05 | 194 | 150 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 5.08e-05 | 194 | 150 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.23e-05 | 195 | 150 | 6 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.23e-05 | 195 | 150 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 5.23e-05 | 195 | 150 | 6 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.23e-05 | 195 | 150 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | mLN-T_cell-gd_T|T_cell / Region, Cell class and subclass | 5.38e-05 | 196 | 150 | 6 | 8f476408cd5a4ea9d25c763c66565343d7989b38 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.38e-05 | 196 | 150 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.53e-05 | 197 | 150 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.43e-06 | 178 | 147 | 9 | 3998_DN | |
| Drug | conta-1(35),3,5,7(37),8,10,12,15,32(36),33-decaene-30-carboxylic acid | 7.19e-06 | 72 | 147 | 6 | CID000489933 | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.37e-05 | 190 | 147 | 8 | 4306_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 3.37e-05 | 190 | 147 | 8 | 2700_UP | |
| Drug | BOCPheONP | 4.14e-05 | 2 | 147 | 2 | CID000111308 | |
| Drug | MPM-06 | 4.14e-05 | 2 | 147 | 2 | CID000161546 | |
| Drug | NSC-374899 | 4.14e-05 | 2 | 147 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 4.14e-05 | 2 | 147 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 4.14e-05 | 2 | 147 | 2 | CID004418081 | |
| Drug | (5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid | 4.14e-05 | 2 | 147 | 2 | ctd:C561635 | |
| Drug | c189 | 4.14e-05 | 2 | 147 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 4.14e-05 | 2 | 147 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 4.14e-05 | 2 | 147 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 4.14e-05 | 2 | 147 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 4.14e-05 | 2 | 147 | 2 | CID000074924 | |
| Drug | p-toluamidine | 4.14e-05 | 2 | 147 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 4.14e-05 | 2 | 147 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 4.14e-05 | 2 | 147 | 2 | CID000011607 | |
| Drug | dimethyloxalylglycine; Down 200; 1000uM; PC3; HG-U133A | 4.20e-05 | 196 | 147 | 8 | 584_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 7003_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 7366_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 2069_DN | |
| Drug | AC1L3JHX | 4.65e-05 | 146 | 147 | 7 | CID000090206 | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 7133_DN | |
| Drug | 2,4,6-tribromoanisole | 5.56e-05 | 12 | 147 | 3 | CID000011839 | |
| Drug | E1-P | 5.90e-05 | 33 | 147 | 4 | CID000104406 | |
| Drug | A-C-A | 7.33e-05 | 67 | 147 | 5 | CID015955872 | |
| Drug | Erp tripeptide | 9.11e-05 | 14 | 147 | 3 | CID000131430 | |
| Drug | N-acetylbenzotriazole | 1.24e-04 | 3 | 147 | 2 | CID000087784 | |
| Drug | photophor | 1.24e-04 | 3 | 147 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 1.24e-04 | 3 | 147 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 1.24e-04 | 3 | 147 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 1.24e-04 | 3 | 147 | 2 | CID000171547 | |
| Drug | AFMeq | 1.24e-04 | 3 | 147 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 1.24e-04 | 3 | 147 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 1.24e-04 | 3 | 147 | 2 | CID000188995 | |
| Drug | AC1L49DM | 1.24e-04 | 3 | 147 | 2 | CID000152933 | |
| Drug | c140 | 1.24e-04 | 3 | 147 | 2 | CID002783250 | |
| Drug | Deuteroporphyrins | 1.24e-04 | 3 | 147 | 2 | ctd:D003905 | |
| Drug | Benzamidomethaneboronic acid | 1.24e-04 | 3 | 147 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 1.24e-04 | 3 | 147 | 2 | CID000076323 | |
| Drug | FK-386 | 1.24e-04 | 3 | 147 | 2 | CID000135044 | |
| Drug | FK-375 | 1.24e-04 | 3 | 147 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 1.24e-04 | 3 | 147 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 1.24e-04 | 3 | 147 | 2 | CID000328214 | |
| Drug | C18 4 | 1.24e-04 | 3 | 147 | 2 | CID000077248 | |
| Drug | taraxastane | 1.24e-04 | 3 | 147 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 1.24e-04 | 3 | 147 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 1.24e-04 | 3 | 147 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 1.24e-04 | 3 | 147 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 1.24e-04 | 3 | 147 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 1.24e-04 | 3 | 147 | 2 | CID000070396 | |
| Drug | Z-Phe-OMe | 1.24e-04 | 3 | 147 | 2 | CID003082435 | |
| Drug | 3-methylcoumarin | 1.24e-04 | 3 | 147 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 1.24e-04 | 3 | 147 | 2 | CID000102124 | |
| Drug | FK-316 | 1.24e-04 | 3 | 147 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 1.24e-04 | 3 | 147 | 2 | CID000000694 | |
| Drug | Marinostatin D | 1.24e-04 | 3 | 147 | 2 | CID000132206 | |
| Drug | 1FD7 | 1.24e-04 | 3 | 147 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 1.24e-04 | 3 | 147 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 1.24e-04 | 3 | 147 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 1.24e-04 | 3 | 147 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 1.24e-04 | 3 | 147 | 2 | CID000193527 | |
| Drug | FK-448 | 1.24e-04 | 3 | 147 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 1.24e-04 | 3 | 147 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 1.24e-04 | 3 | 147 | 2 | CID000133906 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.56e-04 | 177 | 147 | 7 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.67e-04 | 179 | 147 | 7 | 4585_DN | |
| Drug | AC1L2TMY | 1.68e-04 | 17 | 147 | 3 | CID000102826 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.91e-04 | 183 | 147 | 7 | 7498_DN | |
| Drug | heptachlor | 1.94e-04 | 129 | 147 | 6 | CID000003589 | |
| Drug | p203 | 2.00e-04 | 18 | 147 | 3 | CID000019228 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.25e-04 | 188 | 147 | 7 | 6735_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.33e-04 | 189 | 147 | 7 | 4271_DN | |
| Drug | N-acetylphenylalanine | 2.37e-04 | 19 | 147 | 3 | CID000002000 | |
| Drug | Pz-plgpa | 2.37e-04 | 19 | 147 | 3 | CID000152296 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.40e-04 | 190 | 147 | 7 | 4322_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.40e-04 | 190 | 147 | 7 | 2869_DN | |
| Drug | Benzoyl-dl-leucine | 2.46e-04 | 4 | 147 | 2 | CID000294887 | |
| Drug | Acafcek | 2.46e-04 | 4 | 147 | 2 | CID000197677 | |
| Drug | B-1,3-od | 2.46e-04 | 4 | 147 | 2 | CID011971053 | |
| Drug | dehydromerodesmosine | 2.46e-04 | 4 | 147 | 2 | CID006443540 | |
| Drug | alpha-amyrin palmitate | 2.46e-04 | 4 | 147 | 2 | CID000185477 | |
| Drug | poly-THIQ | 2.46e-04 | 4 | 147 | 2 | CID006453487 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 2.46e-04 | 4 | 147 | 2 | CID011548799 | |
| Drug | G2505_sigma | 2.46e-04 | 4 | 147 | 2 | CID000111098 | |
| Drug | Dihydromicrocystin Lr | 2.46e-04 | 4 | 147 | 2 | CID006441227 | |
| Drug | rifamycin SV | 2.46e-04 | 4 | 147 | 2 | ctd:C023808 | |
| Drug | p-fluorobenzenesulfonyl chloride | 2.46e-04 | 4 | 147 | 2 | CID000009588 | |
| Drug | BSSDA | 2.46e-04 | 4 | 147 | 2 | CID003081106 | |
| Drug | microcystin-LF | 2.46e-04 | 4 | 147 | 2 | ctd:C524165 | |
| Drug | AC1L2HV6 | 2.46e-04 | 4 | 147 | 2 | CID000047328 | |
| Drug | AC1L4X1Z | 2.46e-04 | 4 | 147 | 2 | CID000193815 | |
| Drug | NSC-676827 | 2.46e-04 | 4 | 147 | 2 | CID000385555 | |
| Drug | 6-amino-1,2-benzopyrone | 2.46e-04 | 4 | 147 | 2 | CID000046152 | |
| Drug | nitrophenylethanol | 2.46e-04 | 4 | 147 | 2 | CID000097851 | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 192 | 147 | 7 | 6254_DN | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; PC3; HG-U133A | 2.73e-04 | 194 | 147 | 7 | 1953_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.73e-04 | 194 | 147 | 7 | 4312_DN | |
| Drug | 5-Br | 2.77e-04 | 20 | 147 | 3 | CID000008057 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 1.20e-06 | 5 | 147 | 3 | DOID:2741 (implicated_via_orthology) | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 9.95e-06 | 9 | 147 | 3 | EFO_0800562 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 2.47e-05 | 2 | 147 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 2.47e-05 | 2 | 147 | 2 | C0220991 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 2.47e-05 | 2 | 147 | 2 | OBA_2041192 | |
| Disease | Rotor syndrome | 2.47e-05 | 2 | 147 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 2.47e-05 | 2 | 147 | 2 | 237450 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 3.34e-05 | 13 | 147 | 3 | EFO_0800474 | |
| Disease | chymotrypsinogen B measurement | 7.37e-05 | 3 | 147 | 2 | EFO_0801477 | |
| Disease | serum non-albumin protein measurement | 8.70e-05 | 361 | 147 | 9 | EFO_0004568 | |
| Disease | X-23756 measurement | 2.44e-04 | 5 | 147 | 2 | EFO_0022126 | |
| Disease | Renal carcinoma | 2.44e-04 | 5 | 147 | 2 | C1378703 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 3.65e-04 | 6 | 147 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | renal cell carcinoma (implicated_via_orthology) | 3.65e-04 | 6 | 147 | 2 | DOID:4450 (implicated_via_orthology) | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 4.20e-04 | 70 | 147 | 4 | EFO_0008082 | |
| Disease | Nemaline Myopathy, Childhood Onset | 5.09e-04 | 7 | 147 | 2 | C0546125 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 5.09e-04 | 7 | 147 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | seasonal allergic rhinitis | 5.40e-04 | 32 | 147 | 3 | EFO_0003956 | |
| Disease | nemaline myopathy (implicated_via_orthology) | 6.77e-04 | 8 | 147 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | deoxycholic acid glucuronide measurement | 6.77e-04 | 8 | 147 | 2 | EFO_0800575 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 8.67e-04 | 9 | 147 | 2 | C1846707 | |
| Disease | X-21467 measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0020007 | |
| Disease | pancreatitis (biomarker_via_orthology) | 9.71e-04 | 39 | 147 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | information processing speed, cognitive function measurement | 1.08e-03 | 10 | 147 | 2 | EFO_0004363, EFO_0008354 | |
| Disease | Charcot-Marie-Tooth disease | 1.21e-03 | 42 | 147 | 3 | cv:C0007959 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 1.32e-03 | 11 | 147 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | trypsin-2 measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0008305 | |
| Disease | type 1 diabetes mellitus | 1.38e-03 | 242 | 147 | 6 | MONDO_0005147 | |
| Disease | Clear Cell Meningioma | 1.57e-03 | 12 | 147 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 1.57e-03 | 12 | 147 | 2 | C1334271 | |
| Disease | Benign Meningioma | 1.57e-03 | 12 | 147 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 1.57e-03 | 12 | 147 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 1.57e-03 | 12 | 147 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 1.57e-03 | 12 | 147 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 1.57e-03 | 12 | 147 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 1.57e-03 | 12 | 147 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 1.57e-03 | 12 | 147 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 1.57e-03 | 12 | 147 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 1.57e-03 | 12 | 147 | 2 | C0347515 | |
| Disease | Congenital myopathy (disorder) | 1.57e-03 | 12 | 147 | 2 | C0270960 | |
| Disease | Intracranial Meningioma | 1.57e-03 | 12 | 147 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 1.57e-03 | 12 | 147 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 1.57e-03 | 12 | 147 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 1.57e-03 | 12 | 147 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 1.57e-03 | 12 | 147 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 1.57e-03 | 12 | 147 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 1.57e-03 | 12 | 147 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 1.57e-03 | 12 | 147 | 2 | C1384408 | |
| Disease | Secretory meningioma | 1.57e-03 | 12 | 147 | 2 | C1384406 | |
| Disease | Primary Ciliary Dyskinesia | 1.67e-03 | 47 | 147 | 3 | C4551720 | |
| Disease | bilirubin measurement | 1.74e-03 | 442 | 147 | 8 | EFO_0004570 | |
| Disease | cannabis dependence measurement | 1.78e-03 | 48 | 147 | 3 | EFO_0008457 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.85e-03 | 13 | 147 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4 | 1.85e-03 | 13 | 147 | 2 | cv:C4082197 | |
| Disease | cholestasis (biomarker_via_orthology) | 1.89e-03 | 49 | 147 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.16e-03 | 14 | 147 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.62e-03 | 189 | 147 | 5 | EFO_0009932 | |
| Disease | cholesteatoma of middle ear (is_marker_for) | 2.83e-03 | 16 | 147 | 2 | DOID:10964 (is_marker_for) | |
| Disease | response to methotrexate | 2.83e-03 | 16 | 147 | 2 | GO_0031427 | |
| Disease | X-21441 measurement | 3.19e-03 | 17 | 147 | 2 | EFO_0800814 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.19e-03 | 17 | 147 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | oral motor function measurement | 3.19e-03 | 17 | 147 | 2 | EFO_0021793 | |
| Disease | acylcarnitine measurement | 3.80e-03 | 127 | 147 | 4 | EFO_0005059 | |
| Disease | Meningioma | 3.99e-03 | 19 | 147 | 2 | C0025286 | |
| Disease | cystatin C measurement | 4.13e-03 | 402 | 147 | 7 | EFO_0004617 | |
| Disease | memory performance | 4.53e-03 | 409 | 147 | 7 | EFO_0004874 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 4.86e-03 | 21 | 147 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | HbA1c measurement, response to sulfonylurea | 4.86e-03 | 21 | 147 | 2 | EFO_0004541, EFO_0007922 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKIAKVFKNPKFSIL | 101 | Q6GPI1 | |
| KKKETLRDFIFKNPA | 1416 | Q96N23 | |
| KAELLDKFSKKLQPE | 46 | Q8NAA4 | |
| FLPLCRKPVKKKDIF | 256 | Q6Y288 | |
| KIKSTAKFPEQKLFA | 1601 | Q9Y6D6 | |
| AKFPEQKLFAALLIK | 1606 | Q9Y6D6 | |
| KVFNTLLKDKFIPKR | 191 | O14862 | |
| TFIERKLSFEKKKPV | 546 | Q9NXL2 | |
| KEDLEKKLFKPLSQN | 6 | A0A1B0GW35 | |
| KLLKKVALFSKLLPA | 96 | A6NHR8 | |
| FKKVFKKSILALFES | 306 | Q49SQ1 | |
| VRAFAKELFLGKIKK | 36 | Q9H845 | |
| KELFLGKIKKKEVFP | 41 | Q9H845 | |
| QLEEKENKKFPVFKA | 26 | P04080 | |
| KKPELQFVSKARKGL | 356 | Q9Y2F9 | |
| LKFLKKKKPEDAFCV | 156 | Q86W34 | |
| PKLLNKFDKTIKAEL | 331 | Q12797 | |
| RKFSPDLKLLKDVKI | 106 | Q8WYQ5 | |
| KFVTKSSKKSIFVLP | 1836 | Q12830 | |
| VFFRTSPKHKLKIIK | 646 | O75185 | |
| KTLNAIFQGKLEKKF | 1001 | O94823 | |
| LLKLLQKFGKVKQFD | 41 | Q96H35 | |
| FNKFKPGAVERVKKL | 256 | Q8TBY0 | |
| KILKKHKPDFISLFK | 41 | Q92621 | |
| FTLPKVSAKTKFKLT | 836 | Q15334 | |
| SEFAQKLLKKFSLLK | 121 | Q9GZZ8 | |
| KKPFIEKKKAVSFHL | 6 | Q96GA3 | |
| RIPAVKEKISKFFGK | 346 | P34932 | |
| KVLFKFTKVDSRPKE | 516 | Q8NFG4 | |
| FLPKELAAQTIKKSF | 211 | P19827 | |
| ATAKVKPKKLAFSNF | 896 | Q86W92 | |
| EFPLEKKKKFLLFLT | 971 | Q15034 | |
| KKKKFLLFLTGSDRI | 976 | Q15034 | |
| GKFALKIFVKKRQEP | 531 | Q8NBH2 | |
| KLKVFDLLKDEAPQK | 306 | O95671 | |
| DLKKKNQELGKFKFV | 961 | Q96MR6 | |
| KFLVAKRKFKETLRP | 541 | P56696 | |
| KKLFEILNDKKLFKP | 431 | Q5T1V6 | |
| KAKDLLALFNSFKPK | 361 | Q9H501 | |
| CKEKLVPFLKKVGFS | 366 | Q8IYD1 | |
| KKAPVKLESIASVFK | 306 | Q9UKJ3 | |
| FFKIKPLLKSAETEK | 836 | P13535 | |
| LIKSDKFKDIPFNKN | 581 | Q9HCI6 | |
| EIFKTLKFFQTKLKK | 726 | Q6ZR08 | |
| QSAAKAPYLAKFKVK | 1796 | P42356 | |
| PDLQKKIKVLKDAFA | 246 | O60662 | |
| LKIKFPNSLHLKFKE | 461 | Q8IUZ0 | |
| EAKEVLKKLFPKVSV | 1071 | Q86UP2 | |
| LPFVIKFVSRAKKVK | 301 | Q9UMN6 | |
| PLINFKVSSAKFLKD | 171 | P16885 | |
| DFLKGNIKKELFKLA | 56 | P30519 | |
| RKIKDKKLPVGFTFS | 141 | P19367 | |
| ECKEKLVPFLKKVGF | 236 | P15170 | |
| FTIKPLDKKIDVFKF | 271 | P35240 | |
| VLKALSFPKKKAALL | 1041 | Q5TIA1 | |
| IINKKDKDKFPVLVL | 181 | Q9Y5I2 | |
| AKQAFKELLKEKRVP | 396 | O75400 | |
| VEFAPFQKAAKKKTK | 131 | Q9BZI7 | |
| QKKPLAKKVLGDFFE | 266 | P0CF75 | |
| KVFPKEKLKQCKSEF | 1741 | Q14008 | |
| VGKIQKFKVKFSPLD | 3901 | Q4G0P3 | |
| FPKELENKKKELHFL | 281 | Q8WYA0 | |
| KLSKIKSNKKLFELF | 606 | Q96M89 | |
| KIKIDKFKQYIPILS | 931 | Q8TD57 | |
| KLFKLIKTENPAEKL | 161 | P28324 | |
| KQTVFLLEKPFSVKA | 481 | O60678 | |
| IKKLKKELENFDPSF | 2406 | O15078 | |
| IKKPIKTKFRLPVFN | 561 | Q8IVF7 | |
| SKLKFIDPKKIKVFV | 226 | Q9UMR2 | |
| AKTPLKKFLLKLAVS | 366 | Q9ULC5 | |
| LKFKPLSKKVVSAAL | 136 | Q8NDI1 | |
| QEKFFKRKPKVLGVV | 36 | Q96PG1 | |
| FNIDLKEKFTPKKII | 616 | Q16666 | |
| VIFNKKISKNPTFKL | 356 | Q9NX58 | |
| KKFATLPRKESAVKQ | 441 | Q9NV70 | |
| FSLKKFIYALKAPKS | 791 | Q9H583 | |
| LVKLFKFPCLKRGAK | 541 | Q6ZMW3 | |
| APFELLETRKKKNKI | 151 | Q58FG1 | |
| KDFKLFKKIFPSLEL | 761 | Q9NQC7 | |
| KLKFIDPKKIKVFVL | 226 | Q9NUU7 | |
| DIKFLPFKVVEKKTK | 111 | P11021 | |
| KEIPFSVKKTKSIFN | 326 | Q9ULU4 | |
| LKIAKVFKNPKFSIL | 101 | P17538 | |
| KTIIKKLFFFRSGKQ | 196 | Q969X0 | |
| KQLPKEAKRFSNIDK | 1646 | Q8TE73 | |
| FKEKKKVRATLAENP | 76 | Q9BU68 | |
| KKFKEPITSALQKLE | 211 | Q8N7B6 | |
| KLPKQPVIVKAKFFS | 116 | P46776 | |
| PVAKLAKFTFKQKSK | 916 | Q9NXL9 | |
| LSALIVKARKNPKKF | 416 | Q8NAN2 | |
| KDLSKPQLFLKKDIF | 336 | Q5JXM2 | |
| KKIFLFKRVPSINQK | 951 | Q92834 | |
| ACKKLPFEIKNFVKK | 151 | Q6PI48 | |
| LKPKKKVFEKLQADF | 481 | P54577 | |
| KKFSEKVKKNLVPFF | 871 | A6NFQ2 | |
| LLQKVKKVFKASPFL | 196 | O75354 | |
| VQRKKPSVAFKKPIF | 991 | O14513 | |
| KFDPKTKRILTLQKA | 446 | P03956 | |
| KLSPKAKKIYNEFIS | 106 | P49798 | |
| SPEALKFKILVKNKK | 286 | Q86YW0 | |
| FEKLDITPKSAQKIK | 561 | P78424 | |
| AVVEFAPFQKIAKKK | 146 | Q9H1J1 | |
| ILFLNKKDLFGEKIK | 266 | P09471 | |
| LKVKIQDSKFPKDGF | 561 | Q5UE93 | |
| LREFILKAFSKKPKI | 1006 | Q15858 | |
| VFKSAPILKRALKVK | 691 | Q5VSL9 | |
| TNAKFSIKKEAPFVL | 161 | Q96PL2 | |
| AAKELLKKVKFIPGS | 491 | Q9NSE4 | |
| KKFKLSLVGLAKLAF | 351 | G3V0H7 | |
| KTKLNPFKFVGLKNF | 221 | O95149 | |
| KLEISNAIKKTFPFL | 61 | Q9H930 | |
| IIKKFKLNTVGIAKF | 396 | Q9Y6L6 | |
| LAGKPVFKFQLAKFK | 36 | O95968 | |
| TFEKTDLKVPAKAKL | 321 | P51825 | |
| KNFLRLLPKFSLKEK | 221 | P42695 | |
| DKGTKKKFELFVLDP | 121 | Q16280 | |
| PTFKKNFAVLQKKRV | 291 | O75153 | |
| FKELLKQPLEKFELK | 26 | Q7RTR0 | |
| KIKDEFLNAPEKAIK | 776 | Q9BXT8 | |
| KFLARKKFKLPKELI | 116 | Q8NEY3 | |
| LTKQDKLKSPFKFSD | 1636 | O15417 | |
| VTDKKIAILGFAFKK | 326 | O60701 | |
| PGKTRKLLFKFVAKT | 661 | Q7Z392 | |
| KVPKVLVKAKTDTAF | 1151 | Q13009 | |
| AAVVKVPLKKFKSIR | 16 | P20142 | |
| KLPKSVQNKLEKFLA | 16 | P12270 | |
| VQKLGFPAKFLDFKI | 241 | P20226 | |
| FLQNKELFSSLKKGK | 556 | Q8WWL2 | |
| FKLKFLAKVILGKDI | 341 | Q96IC2 | |
| KLKVSKFAISLPKAR | 956 | Q9BXM0 | |
| LATLKPSNKAFEKKF | 906 | P24928 | |
| IIKKFKLSLVGIAKF | 396 | Q9NPD5 | |
| KVEISNAIKKTFPFL | 61 | P23497 | |
| FNLKDPKNNILFKKV | 986 | Q92576 | |
| IILIFLEKPFQKSKF | 986 | Q9NYK1 | |
| LEKPFQKSKFLQLRK | 991 | Q9NYK1 | |
| PFKHDVFLLEKEKKL | 51 | Q14588 | |
| SFVNKLDPSKVFKSK | 241 | Q68CL5 | |
| IQEEKLKPFEKFLLK | 236 | Q2M389 | |
| FKNLECKLLPDKAKV | 106 | Q8N806 | |
| SILPAIFQKKLKQKF | 276 | Q5BJD5 | |
| KIVDDPKALKTLTFK | 506 | Q9UEW8 | |
| RKFFKFQVLKPLDVK | 161 | A5PLN9 | |
| KFGQFPTLKLKSLKR | 341 | O00206 | |
| FLSKDKLFKPSFDVK | 826 | Q92547 | |
| KILEAKTKQLPKFFL | 3446 | Q9Y4A5 | |
| KTKQLPKFFLIEEKC | 3451 | Q9Y4A5 | |
| NAFFLKVTALTKKPD | 146 | Q96RL6 | |
| KLLPFQKDGIIFALK | 36 | Q5FWF4 | |
| AFSTNPELAKKIKIF | 181 | Q5VXJ0 | |
| ILKLKKGKFPFHFVE | 356 | Q9UHQ1 | |
| KNILFVIAKPDVFKS | 1441 | O15069 | |
| ATKLKEKQLFKIFPA | 1521 | Q86UW6 | |
| LAFKKGDLLVLTKKQ | 1521 | Q6PIF6 | |
| LTNFKLKFLSKDIKK | 781 | Q01538 | |
| KAKKFDIKVDAIPLL | 816 | P20929 |